GlassScriptPhysician profile
Katherine Mcgurk
NPI 1154816031
$18,084.26
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $541 · 2021: $824 · 2022: $259 · 2023: $14K · 2024: $2,246 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $3,630 · Food and Beverage: $2,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $3,629.55 |
| Food and Beverage | $2,490.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,455.20 | 2023-2024 | |
| Axogen | $2,538.54 | 2021-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Acumed LLC | $1,537.27 | 2021-2024 | Innate Implant, Acumed, Inframe Implant |
| Medical Device Business Services, INC. | $939.98 | 2019-2021 | |
| Skeletal Dynamics INC | $707.06 | 2023-2025 | Ijs, Align, Geminus |
| Piedmont Plus Innovation | $530.76 | 2023 | |
| Kerecis Limited | $377.14 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $287.73 | 2020-2023 | Na |
| Endo Pharmaceuticals INC. | $226.28 | 2023 | Xiaflex |
| Stryker Corporation | $171.83 | 2020 | |
| Orthofix Medical, INC. | $73.53 | 2024 | Accelstim, Physio-Stim |
| Encore Medical, LP | $69.73 | 2024 | Djo Surgical |
| Peerless Surgical INC. | $67.34 | 2024-2025 | |
| Biocomposites INC | $65.71 | 2024 | |
| Smith+Nephew, INC. | $18.96 | 2025 | Aetos Shoulder System, Real Intelligence, Twinfix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $17.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mcgurk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.